Prelude Therapeutics Incorporated PRLD
$5.67
+2.16%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $6.50
- Implied Upside
- +14.6%
- Price Target Range
- $3.00 – $9.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-29 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $8 |
| 2026-05-04 | D. Boral CapitalJason Kolbert |
Initiates coverage on | Buy | $9 |
| 2026-04-27 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $5 → $8 |
| 2026-03-11 | CitizensReni Benjamin |
Maintains | Market outperform | $3 → $6 |
| 2025-09-23 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $5 |
| 2025-08-18 | JMP SecuritiesReni J. Benjamin |
Maintains | Market outperform | $4 → $3 |
| 2025-05-05 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $5 |
| 2025-04-29 | JMP SecuritiesReni Benjamin |
Reiterates | Market outperform | $4 |
| 2025-04-08 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $5 |
| 2025-03-12 | Citizens Capital MarketsReni Benjamin |
Reiterates | Market outperform | $4 |
| 2024-12-11 | JMP SecuritiesReni Benjamin |
Reiterates | Market outperform | $7 → $4 |
| 2024-11-08 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $5 |
| 2024-10-28 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $5 |
| 2024-09-19 | HC Wainwright & Co.Robert Burns |
Upgrades | Neutral → Buy | $5 |
| 2024-09-16 | JMP SecuritiesReni Benjamin |
Reiterates | Market outperform | $7 |
| 2024-09-16 | HC Wainwright & Co.Robert Burns |
Reiterates | Neutral | $5 |
| 2024-09-10 | HC Wainwright & Co.Robert Burns |
Reiterates | Neutral | $5 |
| 2024-08-15 | HC Wainwright & Co.Robert Burns |
Reiterates | Neutral | $5 |
| 2024-03-13 | JMP SecuritiesReni Benjamin |
Initiates coverage on | Market outperform | $7 |
| 2024-02-20 | HC Wainwright & Co.Robert Burns |
Downgrades | Buy → Neutral | $5 |
| 2023-12-19 | Morgan StanleyJeffrey Hung |
Downgrades | Equal-weight → Underweight | $10 → $4 |
| 2023-11-07 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $6 → $5 |
| 2023-10-19 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $17 → $6 |
| 2023-08-17 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $17 |
| 2023-08-04 | Morgan StanleyJeffrey Hung |
Reiterates | Equal-weight | $10 |
| 2023-08-04 | BarclaysPeter Lawson |
Maintains | Equal-weight | $7 → $5 |
| 2023-03-17 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $15 → $17 |
| 2022-11-21 | B of A SecuritiesTazeen Ahmad |
Downgrades | Neutral → Underperform | $6 |
| 2022-11-17 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $16 → $15 |
| 2022-11-15 | Morgan StanleyJeffrey Hung |
Maintains | Equal-weight | $11 → $10 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.67
- Market Cap
- $442.91 million
- 52-Week Range
- $0.75 – $5.91
- Average Volume
- 371K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.